Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Aparicio

Showing results (31-40 of 199) with videos related to

Pageof 20
Sort By:
Targeted Oncology|September 8, 2023
Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal CancerAmandine Gouverneur, Clélia Favary, Jérémy Jové, et al.
Obesity Surgery|December 13, 2007
Expression of ghrelin in fundus is increased after gastric banding in morbidly obese patientsBernard Uzzan, Jean-Marc Catheline, Christine Lagorce, et al.
Targeted Oncology|October 13, 2017
Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer between Elderly and Younger Patients: a Study Using the International Pharmacovigilance DatabaseAmandine Gouverneur, Pauline Claraz, Marine Rousset, et al.
Gastroenterologie Clinique Et Biologique|July 18, 2002
[The management of patients who test positive for hepatitis C in a free and anonymous testing centre is critical for follow-up]Thomas Aparicio, Laurent Zouari, Laurent Abramowitz, et al.
European Radiology|May 20, 2026
AI-driven volumetric approach for automatic chemotherapy response assessment in colorectal liver metastasesMarwan Abbas, Gustavo Andrade-Miranda, Vincent Bourbonne, et al.
Clinics and Research in Hepatology and Gastroenterology|October 27, 2015
Safety and efficacy of palliative systemic chemotherapy combined with colorectal self-expandable metallic stents in advanced colorectal cancer: A multicenter studyNicolas Cézé, Antoine Charachon, Christophe Locher, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 5, 2020
Sarcopenia: An important prognostic factor for males treated for a locally advanced esophageal carcinomaBethsabee Benadon, Stéphanie Servagi-Vernat, Laurent Quero, et al.
Critical Reviews in Oncology/Hematology|January 10, 2009
Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatmentThomas Aparicio, Atika Navazesh, Isabelle Boutron, et al.
Cancer Investigation|March 16, 2006
Phase II trial alternating FOLFOX-6 and FOLFIRI regimens in second-line therapy of patients with metastatic colorectal cancer (FIREFOX study)Mohamed Hebbar, Christophe Tournigand, Gérard Lledo, et al.
Journal of Geriatric Oncology|February 26, 2017
Impaired mobility, depressed mood, cognitive impairment and polypharmacy are independently associated with disability in older cancer outpatients: The prospective Physical Frailty in Elderly Cancer patients (PF-EC) cohort studyFrederic Pamoukdjian, Thomas Aparicio, Laurent Zelek, et al.
Pageof 20

Showing results (31-40 of 199) with videos related to

Sort By:
Pageof 20
Targeted Oncology|September 8, 2023
Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal CancerAmandine Gouverneur, Clélia Favary, Jérémy Jové, et al.
Obesity Surgery|December 13, 2007
Expression of ghrelin in fundus is increased after gastric banding in morbidly obese patientsBernard Uzzan, Jean-Marc Catheline, Christine Lagorce, et al.
Targeted Oncology|October 13, 2017
Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer between Elderly and Younger Patients: a Study Using the International Pharmacovigilance DatabaseAmandine Gouverneur, Pauline Claraz, Marine Rousset, et al.
Gastroenterologie Clinique Et Biologique|July 18, 2002
[The management of patients who test positive for hepatitis C in a free and anonymous testing centre is critical for follow-up]Thomas Aparicio, Laurent Zouari, Laurent Abramowitz, et al.
European Radiology|May 20, 2026
AI-driven volumetric approach for automatic chemotherapy response assessment in colorectal liver metastasesMarwan Abbas, Gustavo Andrade-Miranda, Vincent Bourbonne, et al.
Clinics and Research in Hepatology and Gastroenterology|October 27, 2015
Safety and efficacy of palliative systemic chemotherapy combined with colorectal self-expandable metallic stents in advanced colorectal cancer: A multicenter studyNicolas Cézé, Antoine Charachon, Christophe Locher, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 5, 2020
Sarcopenia: An important prognostic factor for males treated for a locally advanced esophageal carcinomaBethsabee Benadon, Stéphanie Servagi-Vernat, Laurent Quero, et al.
Critical Reviews in Oncology/Hematology|January 10, 2009
Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatmentThomas Aparicio, Atika Navazesh, Isabelle Boutron, et al.
Cancer Investigation|March 16, 2006
Phase II trial alternating FOLFOX-6 and FOLFIRI regimens in second-line therapy of patients with metastatic colorectal cancer (FIREFOX study)Mohamed Hebbar, Christophe Tournigand, Gérard Lledo, et al.
Journal of Geriatric Oncology|February 26, 2017
Impaired mobility, depressed mood, cognitive impairment and polypharmacy are independently associated with disability in older cancer outpatients: The prospective Physical Frailty in Elderly Cancer patients (PF-EC) cohort studyFrederic Pamoukdjian, Thomas Aparicio, Laurent Zelek, et al.
Pageof 20